Sonoma Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Sonoma Pharmaceuticals Inc.: Is Infosys Ltd. worth buying?
Item: Sonoma Pharmaceuticals Inc.
Rating: 1.62350
Author: Trendlyne DVM scores

about

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focu...

3.34 -0.05 (-1.47%)

51.73% Fall from 52W High

5,749

XNAS Volume

XNAS 29 Jan, 2026 4:30 PM (EST)

Board Meeting

The next board meeting for Sonoma Pharma Inc is on 05 Feb 2026 for the purpose of Sonoma Pharmaceuticals Inc Third Quarter Earnings Results for 2026 See details

Not Eligible

Expensive Valuation

28.0 / 100

Technically Neutral

36.9 / 100

1Yr Price target upside is 301%

2 analysts

Sonoma Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Sonoma Pharma Inc Live Stock Price Today, Share Analysis and Chart

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focu...

51.73% Fall from 52W High

SWOT Analysis

Sonoma Pharma Inc Live Price Chart